INOFEA

INOFEA, a Swiss biotech company founded in 2014, offers enzyme-based solutions for the synthesis of Biologics like mRNA vaccines, therapeutics, and ADCs. Our patented technology enhances enzyme stability and activity without loss during the process, resulting in purer products, cost-saving potential, and faster market entry. The technology is also successfully applied in biocatalytic process steps for small molecule APIs where soluble enzymes would be insufficiently stable, preserving activity under challenging conditions.